Asthmatics warned avoiding flu jab is like ‘playing Russian roulette’
Posted on October 17, 2018
Source: Denis Campbell Health policy editor, The Guardian, Wed 17 Oct 2018.
Britain’s 5.4 million asthma sufferers are “playing Russian roulette with their life” if they do not have the flu jab before this winter, doctors are warning.
Asthmatics need to get immunised because colds and flu are the main trigger for potential fatal flare-ups of the disease, according to the charity AsthmaUK.
Most asthmatics are entitled to a flu jab free on the NHS as they are classed as a vulnerable group. But a poll has found that almost one in four people with asthma do not plan to have the jab ahead of the cold spell.
“Unfortunately there are lots of myths about the flu jab not working, causing side-effects or causing flu, and our research shows this is preventing people from getting it.”
Deaths from flu and deaths from serious breathing problems both peak during winter. Asthma claimed 1,410 lives during 2016, the last year for which full-year figures are available.
Activ8rlives says: Good Asthma control in both children and adults includes understanding the causes of Asthma Attacks, avoiding your triggers, getting your annual flu jab and taking your medication as prescribed, even if you feel well. Activ8rlives’ Asthma+me paediatric Asthma solution provides a complete integrated and interactive Asthma solution and is available soon. To receive information about Asthma+me register your interest here.
Aseptika’s Asthma+me solution announced as Winner of Best Patient-Focused Technological Development in 2019 Clinical & Research Excellence Awards
Posted on May 7, 2019
Self-care: Councils helping people look after themselves
Posted on March 11, 2019
Asthma: Young people in the UK 'more likely to die'
Posted on February 20, 2019
Young people are at higher risk of having an asthma attack than any other age group living with the condition, the charity Asthma UK is warning
Posted on January 23, 2019
Aseptika wins grant from Innovate UK to undertake a clinical trial with its child asthma solution
Posted on January 21, 2019